Prime Medicine Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.21

+0.10 (+3.05%)

As of May 9, 1:44 AM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 14 74%

Hold 5 26%

Sell 0 0%

Price Target

Analyst Price Target +1,245.5% upside

Low Target $33.60

Average Target $43.19

High Target $71.66

Current Price $3.21

Current
$3.21

Target
$43.19

$33.60 $43.19 avg $71.66

Scenario Analysis

Bear Case

$33.60

946.7%

Low target

Base Case

$43.19

+1,245.5%

Avg target

Bull Case

$71.66

+2,132.4%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$6.94

-53.7% from high

52-Week Low

$1.11

+189.2% from low

Target vs 52W High

$43.19

+522.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%